Similar articles for PMID: 21128892

Year	Number of Results
1996	1
1997	1
2001	1
2002	3
2003	9
2004	9
2005	11
2006	7
2007	4
2008	3
2009	3
2010	8
2011	8
2012	6
2013	4
2014	8
2015	8
2017	5
2018	7
2019	8
2020	7
2021	12
2022	6
2023	4
2024	0

1

Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?

Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Athyros VG, et al. Curr Pharm Des. 2010;16(34):3939-847. doi: 10.2174/138161210794455085. Curr Pharm Des. 2010. PMID: 21128892 Review.

2

Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.

Petersen JL, McGuire DK. Petersen JL, et al. Diab Vasc Dis Res. 2005 Feb;2(1):9-15. doi: 10.3132/dvdr.2005.007. Diab Vasc Dis Res. 2005. PMID: 16305067 Free article. Review.

3

[Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].

Flórez H. Flórez H. Invest Clin. 1997 Mar;38(1):39-52. Invest Clin. 1997. PMID: 9235072 Review. Spanish.

4

The prevention of type 2 diabetes: what is the evidence?

Chiasson JL, Brindisi MC, Rabasa-Lhoret R. Chiasson JL, et al. Minerva Endocrinol. 2005 Sep;30(3):179-91. Minerva Endocrinol. 2005. PMID: 16208307 Review.

5

Pharmacological and surgical intervention for the prevention of diabetes.

Chiasson JL. Chiasson JL. Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:31-42. doi: 10.1159/000094404. Nestle Nutr Workshop Ser Clin Perform Programme. 2006. PMID: 16820729 Review.

6

The prevention of type 2 diabetes.

Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM; Diabetes Prevention Program Research Group. Crandall JP, et al. Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93. doi: 10.1038/ncpendmet0843. Epub 2008 May 20. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18493227 Free PMC article. Review.

7

Preservation of β-cell function: the key to diabetes prevention.

DeFronzo RA, Abdul-Ghani MA. DeFronzo RA, et al. J Clin Endocrinol Metab. 2011 Aug;96(8):2354-66. doi: 10.1210/jc.2011-0246. Epub 2011 Jun 22. J Clin Endocrinol Metab. 2011. PMID: 21697254 Review.

8

Reflecting on type 2 diabetes prevention: more questions than answers!

Rosenstock J. Rosenstock J. Diabetes Obes Metab. 2007 Sep;9 Suppl 1:3-11. doi: 10.1111/j.1463-1326.2007.00768.x. Diabetes Obes Metab. 2007. PMID: 17877541 Review.

9

What are the pharmacotherapy options for treating prediabetes?

Daniele G, Abdul-Ghani M, DeFronzo RA. Daniele G, et al. Expert Opin Pharmacother. 2014 Oct;15(14):2003-18. doi: 10.1517/14656566.2014.944160. Epub 2014 Aug 19. Expert Opin Pharmacother. 2014. PMID: 25139488 Review.

10

Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.

Smith-Marsh D. Smith-Marsh D. Drugs Today (Barc). 2013 Aug;49(8):499-507. doi: 10.1358/dot.2013.49.8.2002839. Drugs Today (Barc). 2013. PMID: 23977667 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

137 results

Results by year